Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Roche for InfoPages here.
Roche - Latest News [Page 3]
Open ended immunosuppressant access
Thursday, 29 September 2005, 12:35 am | Roche
New Zealand kidney and heart transplant patients will have open ended access to the immunosuppressant Cellcept®(mycophenolate mofetil) from October 1st. More >>
Collaboration on additional funding for treatment
Tuesday, 6 September 2005, 4:32 pm | Roche
Auckland, 6th September 2005 – Roche Products (New Zealand) Ltd and Government drug funding agency PHARMAC are working collaboratively, to ensure rapid assessment for funding of breast cancer treatment Herceptin (trastuzumab) for women ... More >>
$100,000 for HER2 breast cancer testing
Tuesday, 6 September 2005, 4:30 pm | Roche
$100,000 for HER2 breast cancer testing - Every woman with breast cancer can determine her HER2 status More >>
Research shows breast cancer reoccurrence halved
Friday, 3 June 2005, 10:53 am | Roche
Local research shows breast cancer reoccurrence rates halved New Zealand women and local researchers contribute to landmark study More >>
Xenical available from pharmacists
Friday, 11 March 2005, 1:52 pm | Roche
Auckland, March 10 2005 – Weight loss medication Xenical® (orlistat) is now available direct from a pharmacist for the first time in New Zealand. Xenical has been re-classified to a pharmacist only medicine meaning pharmacists can sell Xenical to appropriate ... More >>
MCC agrees Xenical safe for pharmacy
Thursday, 24 June 2004, 2:15 pm | Roche
Auckland, 24 June 2004 – The safety profile of weight loss medication Xenical® (orlistat) has been deemed suitable for sale over the counter in New Zealand pharmacies by the Medicines Classification Committee (a Ministerial Advisory Committee. More >>
Statement from Roche Products (New Zealand) Ltd
Friday, 30 April 2004, 12:40 am | Roche
Concerns from New Zealand doctors regarding Xenical reclassification are unfounded More >>
More patients expected to survive blood cancer
Monday, 2 February 2004, 3:00 pm | Roche
Auckland, 2nd February 2004 – Each year an additional 30 - 35 people2 who are diagnosed with aggressive blood cancer may live beyond 2006 thanks to a new funding agreement for targeted cancer therapy MabThera. More >>
Urgent Message From Roche Consumer Health
Wednesday, 30 April 2003, 5:23 pm | Roche
Auckland 29th April, 2003 - Roche Consumer Health (NZ) is the name behind some of the country’s most popular pharmaceutical brands including Berocca, Elevit, Redoxon, Supradyn, Aspro, Naprogesic and Cepacol. In the wake of the Pan Pharmaceuticals product ... More >>
Preventing Type 2 Diabetes
Tuesday, 27 August 2002, 7:44 am | Roche
Roche announced today that the results of the four year landmark XENDOS study involving 3304 obese patients demonstrated that the weight loss medication Xenical can prevent or delay the development of type 2 diabetes. Furthermore, the XENDOS study data showed ... More >>
